Drug Profile
Research programme: levothyroxine sodium - IPE
Alternative Names: BCT304; Sustained-release levothyroxine sodium; Sustained-release T4Latest Information Update: 01 Jan 2022
Price :
$50
*
At a glance
- Originator IPE
- Class Aromatic amino acids; Small molecules; Thyroid hormones
- Mechanism of Action Thyroid hormone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypothyroidism
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hypothyroidism in USA (Controlled release)
- 29 Jan 2013 Preclinical trials in Hypothyroidism in USA (unspecified route)